EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Titel:
EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
Auteur:
Almstedt, K. Mendoza, S. Otto, M. Battista, M. J. Steetskamp, J. Heimes, A. S. Krajnak, S. Poplawski, A. Gerhold-Ay, A. Hasenburg, A. Denkert, C. Schmidt, M.